{"id":"dosulepin","rwe":[{"pmid":"41522586","year":"2025","title":"Comparative Efficacy and Safety of SSRIs and TCAs in the Management of Major Depressive Disorder: A Prospective Observational Study.","finding":"","journal":"Journal of pharmacy & bioallied sciences","studyType":"Clinical Study"},{"pmid":"30000819","year":"2006","title":"Dothiepin.","finding":"","journal":"","studyType":"Clinical Study"},{"pmid":"39583597","year":"2024","title":"Drug-Induced Type 1 Brugada Pattern: A Case Report.","finding":"","journal":"Cureus","studyType":"Clinical Study"},{"pmid":"38827015","year":"2024","title":"The cardiovascular safety of tricyclic antidepressants in overdose and in clinical use.","finding":"","journal":"Therapeutic advances in psychopharmacology","studyType":"Clinical Study"},{"pmid":"38489675","year":"2024","title":"Effect of lipid emulsion on neuropsychiatric drug-induced toxicity: A narrative review.","finding":"","journal":"Medicine","studyType":"Clinical Study"}],"tags":[{"label":"Tricyclic Antidepressants","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Histamine H1 receptor","category":"target"},{"label":"HRH1","category":"gene"},{"label":"SLC6A4","category":"gene"},{"label":"ADRA2B","category":"gene"},{"label":"N06AA16","category":"atc"},{"label":"Active","category":"status"},{"label":"Major depressive disorder","category":"indication"},{"label":"Adrenergic Agents","category":"pharmacology"},{"label":"Adrenergic Uptake Inhibitors","category":"pharmacology"},{"label":"Antidepressive Agents","category":"pharmacology"},{"label":"Antidepressive Agents, Tricyclic","category":"pharmacology"},{"label":"Central Nervous System Agents","category":"pharmacology"},{"label":"Membrane Transport Modulators","category":"pharmacology"},{"label":"Neurotransmitter Agents","category":"pharmacology"},{"label":"Neurotransmitter Uptake Inhibitors","category":"pharmacology"},{"label":"Psychotropic Drugs","category":"pharmacology"}],"phase":"marketed","safety":{"safetySignals":[{"llr":166.403,"date":"","count":47,"signal":"Head discomfort","source":"DrugCentral FAERS","actionTaken":"Reported 47 times (LLR=166)"},{"llr":99.049,"date":"","count":47,"signal":"Neck pain","source":"DrugCentral FAERS","actionTaken":"Reported 47 times (LLR=99)"},{"llr":87.64,"date":"","count":47,"signal":"Migraine","source":"DrugCentral FAERS","actionTaken":"Reported 47 times (LLR=88)"},{"llr":57.76,"date":"","count":57,"signal":"Back pain","source":"DrugCentral FAERS","actionTaken":"Reported 57 times (LLR=58)"},{"llr":40.283,"date":"","count":52,"signal":"Toxicity to various agents","source":"DrugCentral FAERS","actionTaken":"Reported 52 times (LLR=40)"},{"llr":38.712,"date":"","count":34,"signal":"Hyponatraemia","source":"DrugCentral FAERS","actionTaken":"Reported 34 times (LLR=39)"},{"llr":37.431,"date":"","count":69,"signal":"Headache","source":"DrugCentral FAERS","actionTaken":"Reported 69 times (LLR=37)"},{"llr":33.102,"date":"","count":21,"signal":"Lactic acidosis","source":"DrugCentral FAERS","actionTaken":"Reported 21 times (LLR=33)"},{"llr":31.128,"date":"","count":9,"signal":"Anticholinergic syndrome","source":"DrugCentral FAERS","actionTaken":"Reported 9 times (LLR=31)"},{"llr":30.34,"date":"","count":10,"signal":"Cardiac valve disease","source":"DrugCentral FAERS","actionTaken":"Reported 10 times (LLR=30)"}],"drugInteractions":[{"url":"/drug/high-risk-qt-prolonging-agents","drug":"High Risk QT Prolonging Agents","action":"Avoid combination","effect":"Highest Risk QTc-Prolonging Agents may enhance the QTc-prolonging effect of other Highest Risk QTc-Prolonging Agents","source":"DrugCentral","drugSlug":"high-risk-qt-prolonging-agents"}],"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Dosulepin","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:04:43.390015+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:04:49.698868+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Dosulepin","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:04:50.060151+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1711280/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:04:50.766203+00:00"}},"allNames":"dothiepin","offLabel":[],"synonyms":["dosulepin","dosulepine","dothiepin","prothiaden","prothiadene","dosulepin hydrochloride","dothiepin hydrochloride","dosulepin HCl","dothiepin HCl"],"timeline":[{"date":"1962-01-01","type":"positive","source":"DrugCentral","milestone":"YEAR INTRODUCED approval"}],"approvals":[{"date":"1962-01-01","orphan":false,"company":"","regulator":"YEAR INTRODUCED"}],"brandName":"Dothiepin","ecosystem":[{"indication":"Major depressive disorder","otherDrugs":[{"name":"brexpiprazole","slug":"brexpiprazole","company":"Otsuka Pharm Co Ltd"},{"name":"bupropion","slug":"bupropion","company":"Glaxosmithkline"},{"name":"citalopram","slug":"citalopram","company":"Forest Labs"},{"name":"desvenlafaxine","slug":"desvenlafaxine","company":"Wyeth Pharms Inc"}],"globalPrevalence":280000000}],"mechanism":{"target":"Histamine H1 receptor","targets":[{"gene":"HRH1","source":"DrugCentral","target":"Histamine H1 receptor","protein":"Histamine H1 receptor"},{"gene":"SLC6A4","source":"DrugCentral","target":"Sodium-dependent serotonin transporter","protein":"Sodium-dependent serotonin transporter"},{"gene":"ADRA2B","source":"DrugCentral","target":"Alpha-2B adrenergic receptor","protein":"Alpha-2B adrenergic receptor"},{"gene":"CHRM1","source":"DrugCentral","target":"Muscarinic acetylcholine receptor M1","protein":"Muscarinic acetylcholine receptor M1"},{"gene":"CHRM3","source":"DrugCentral","target":"Muscarinic acetylcholine receptor M3","protein":"Muscarinic acetylcholine receptor M3"},{"gene":"SLC6A2","source":"DrugCentral","target":"Sodium-dependent noradrenaline transporter","protein":"Sodium-dependent noradrenaline transporter"},{"gene":"CHRM4","source":"DrugCentral","target":"Muscarinic acetylcholine receptor M4","protein":"Muscarinic acetylcholine receptor M4"},{"gene":"CHRM5","source":"DrugCentral","target":"Muscarinic acetylcholine receptor M5","protein":"Muscarinic acetylcholine receptor M5"},{"gene":"CHRM2","source":"DrugCentral","target":"Muscarinic acetylcholine receptor M2","protein":"Muscarinic acetylcholine receptor M2"},{"gene":"HTR2A","source":"DrugCentral","target":"5-hydroxytryptamine receptor 2A","protein":"5-hydroxytryptamine receptor 2A"}],"modality":"Small Molecule","drugClass":"Tricyclic Antidepressants","explanation":"","oneSentence":"","technicalDetail":"Dothiepin exerts its antidepressant effects through a combination of histamine H1 receptor antagonism and inhibition of the reuptake of serotonin and norepinephrine, which increases the availability of these neurotransmitters in the synaptic cleft and enhances their postsynaptic effects."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/951","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=Dosulepin","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Dosulepin","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T10:46:20.293849","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:04:52.437297+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"desipramine","drugSlug":"desipramine","fdaApproval":"1964-11-20","genericCount":8,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"imipramine","drugSlug":"imipramine","fdaApproval":"1959-04-16","genericCount":3,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"clomipramine","drugSlug":"clomipramine","fdaApproval":"1989-12-29","genericCount":19,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"trimipramine","drugSlug":"trimipramine","fdaApproval":"1979-06-12","genericCount":3,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"amitriptyline","drugSlug":"amitriptyline","fdaApproval":"1961-04-07","genericCount":33,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"nortriptyline","drugSlug":"nortriptyline","fdaApproval":"1964-11-06","genericCount":9,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"protriptyline","drugSlug":"protriptyline","fdaApproval":"1967-09-27","genericCount":4,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"doxepin","drugSlug":"doxepin","fdaApproval":"1969-09-23","patentExpiry":"Sep 7, 2030","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"amoxapine","drugSlug":"amoxapine","fdaApproval":"1980-09-22","genericCount":3,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"maprotiline","drugSlug":"maprotiline","fdaApproval":"1980-12-01","genericCount":4,"patentStatus":"Off-patent — generic available","relationship":"same-class"}],"genericName":"dosulepin","indications":{"approved":[{"name":"Major depressive disorder","source":"DrugCentral","snomedId":370143000,"regulator":"FDA","usPrevalence":21000000,"globalPrevalence":280000000,"prevalenceMethod":"curated","prevalenceSource":"WHO, 2023"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"desipramine","brandName":"desipramine","genericName":"desipramine","approvalYear":"1964","relationship":"same-class"},{"drugId":"imipramine","brandName":"imipramine","genericName":"imipramine","approvalYear":"1959","relationship":"same-class"},{"drugId":"clomipramine","brandName":"clomipramine","genericName":"clomipramine","approvalYear":"1989","relationship":"same-class"},{"drugId":"trimipramine","brandName":"trimipramine","genericName":"trimipramine","approvalYear":"1979","relationship":"same-class"},{"drugId":"amitriptyline","brandName":"amitriptyline","genericName":"amitriptyline","approvalYear":"1961","relationship":"same-class"},{"drugId":"nortriptyline","brandName":"nortriptyline","genericName":"nortriptyline","approvalYear":"1964","relationship":"same-class"},{"drugId":"protriptyline","brandName":"protriptyline","genericName":"protriptyline","approvalYear":"1967","relationship":"same-class"},{"drugId":"doxepin","brandName":"doxepin","genericName":"doxepin","approvalYear":"1969","relationship":"same-class"},{"drugId":"amoxapine","brandName":"amoxapine","genericName":"amoxapine","approvalYear":"1980","relationship":"same-class"},{"drugId":"maprotiline","brandName":"maprotiline","genericName":"maprotiline","approvalYear":"1980","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT06803485","phase":"PHASE4","title":"Effect of Venlafaxine Versus Dosulepin in Pain Predominant Somatic Symptom Disorder","status":"RECRUITING","sponsor":"All India Institute of Medical Sciences, Bhubaneswar","startDate":"2025-03-11","conditions":["Somatic Symptom Disorder (DSM-V)"],"enrollment":84,"completionDate":"2026-11"},{"nctId":"NCT05952713","phase":"","title":"Comparative Responses to 15 Different Antidepressants in Major Depressive Disorder","status":"COMPLETED","sponsor":"Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital","startDate":"2022-10-01","conditions":["Major Depressive Disorder"],"enrollment":73336,"completionDate":"2023-07-01"},{"nctId":"NCT03126188","phase":"","title":"Study of the Effect of Antidepressant Drugs on Neurotrophic Factors in Patients With Depression","status":"COMPLETED","sponsor":"All India Institute of Medical Sciences, Bhubaneswar","startDate":"2017-04-05","conditions":["Depressive Episode"],"enrollment":105,"completionDate":"2018-02-28"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NUI":"N0000167275","NDDF":"003960","UNII":"W13O82Z7HL","CHEBI":"CHEBI:36798","INN_ID":"1790","RXNORM":"142133","UMLSCUI":"C0013065","chemblId":"CHEMBL1711280","ChEMBL_ID":"CHEMBL1492500","KEGG_DRUG":"D01546","DRUGBANK_ID":"DB09167","PUBCHEM_CID":"5284550","SNOMEDCT_US":"349856007","IUPHAR_LIGAND_ID":"7549","SECONDARY_CAS_RN":"897-15-4","MESH_DESCRIPTOR_UI":"D004308"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","bioavailability":"30%"},"publicationCount":78,"therapeuticAreas":["Neuroscience"],"atcClassification":{"source":"DrugCentral","atcCode":"N06AA16","allCodes":["N06AA16"]},"biosimilarFilings":[],"recentPublications":[{"date":"2025 Oct-Dec","pmid":"41522586","title":"Comparative Efficacy and Safety of SSRIs and TCAs in the Management of Major Depressive Disorder: A Prospective Observational Study.","journal":"Journal of pharmacy & bioallied sciences"},{"date":"2006","pmid":"30000819","title":"Dothiepin.","journal":""},{"date":"2024 Nov","pmid":"39583597","title":"Drug-Induced Type 1 Brugada Pattern: A Case Report.","journal":"Cureus"},{"date":"2024","pmid":"38827015","title":"The cardiovascular safety of tricyclic antidepressants in overdose and in clinical use.","journal":"Therapeutic advances in psychopharmacology"},{"date":"2024 Mar 15","pmid":"38489675","title":"Effect of lipid emulsion on neuropsychiatric drug-induced toxicity: A narrative review.","journal":"Medicine"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"All India Institute of Medical Sciences, Bhubaneswar","companyId":"all-india-institute-of-medical-sciences-bhubaneswar","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"OTHER","regulator":"YEAR INTRODUCED","status":"approved","approval_date":"1962-01-01T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:04:52.437297+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}